Correlation between intima-to-media ratio, apolipoprotein B-100, myeloperoxidase, and hypochlorite-oxidized proteins in human atherosclerosis.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Free Radical Biology & Medicine

• Publication date

  2001-11-15

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/S0891-5849(01)00717-1PMID 11705704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.

  2001cited by this paper
• Hypochlorite-modified Low Density Lipoprotein Inhibits Nitric Oxide Synthesis in Endothelial Cells via an Intracellular Dislocalization of Endothelial Nitric-oxide Synthase*

  2001cited by this paper
• Increased atherosclerosis in myeloperoxidase-deficient mice.

  2001cited by this paper
• Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.

  2000cited by this paper
• Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions.

  2000cited by this paper
• p-Hydroxyphenylacetaldehyde, an Aldehyde Generated by Myeloperoxidase, Modifies Phospholipid Amino Groups of Low Density Lipoprotein in Human Atherosclerotic Intima*

  2000cited by this paper
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall

  1999cited by this paper
• Mechanism of hypochlorite-mediated inactivation of proteinase inhibition by alpha 2-macroglobulin.

  1999cited by this paper
• Tocopherol‐mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement

  1999cited by this paper
• Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.

  1999cited by this paper
• Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice.

  1999cited by this paper
• Dietary and pharmacological antioxidants in atherosclerosis.

  1999cited by this paper
• Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.

  1998cited by this paper
• Quantification of alterations in structure and function of elastin in the arterial media.

  1998cited by this paper
• Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque.

  1998cited by this paper
• The oxidative inactivation of tissue inhibitor of metalloproteinase-1 (TIMP-1) by hypochlorous acid (HOCI) is suppressed by anti-rheumatic drugs.

  1998cited by this paper
• The Molecular Action of α-Tocopherol in Lipoprotein Lipid Peroxidation

  1998cited by this paper
• Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing.

  1998cited by this paper
• The molecular action of alpha-tocopherol in lipoprotein lipid peroxidation. Pro- and antioxidant activity of vitamin E in complex heterogeneous lipid emulsions.

  1998cited by this paper
• Antioxidants and atherosclerotic heart disease.

  1997cited by this paper
• Reactive Nitrogen Intermediates Promote Low Density Lipoprotein Oxidation in Human Atherosclerotic Intima*

  1997cited by this paper
• Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein.

  1997cited by this paper
• α‐Tocopherol does not inhibit hypochlorite‐induced oxidation of apolipoprotein B‐100 of low‐density lipoprotein

  1997cited by this paper
• 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.

  1997cited by this paper
• Presence of hypochlorite-modified proteins in human atherosclerotic lesions.

  1996cited by this paper
• Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.

  1995cited by this paper
• Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies.

  1995cited by this paper
• Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

  1994cited by this paper
• Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry.

  1994cited by this paper
• A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1994cited by this paper
• Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

  1994cited by this paper
• Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation.

  1994cited by this paper
• Involvement of 15-lipoxygenase in early stages of atherogenesis

  1994cited by this paper
• A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1994cited by this paper
• Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages.

  1993cited by this paper
• Potential roles of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis.

  1993cited by this paper
• Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison.

  1992cited by this paper
• A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

  1992cited by this paper
• Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults.

  1992cited by this paper
• Oxidative damage to fibronectin. I. The effects of the neutrophil myeloperoxidase system and HOCl.

  1991cited by this paper
• Enhancement of immunogenic properties of ovalbumin as a result of its chlorination.

  1991cited by this paper
• Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases.

  1990cited by this paper
• Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions.

  1990cited by this paper
• Immune mechanisms in atherosclerosis.

  1989cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Immune mechanisms in atherosclerosis.

  1989cited by this paper
• Arterial elastin as seen with scanning electron microscopy: a review.

  1988cited by this paper
• Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children.

  1987cited by this paper
• Inflammatory infiltrates in human coronary atherosclerosis.

  1986cited by this paper
• Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque.

  1985cited by this paper
• Primer of biostatistics : statistical software program version 6.0

  1981cited by this paper
• Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system.

  1979cited by this paper
• Apo B concentration in the normal human aorta.

  1978cited by this paper

• Human serum albumin modified in myeloperoxidase-dependent reactions is a mediator of neutrophil extracellular trap formation.

  2025cites this paper
• Free Radical Lipid Peroxidation Induced by Reactive Halogen Species

  2024cites this paper
• Myeloperoxidase as a Promising Therapeutic Target after Myocardial Infarction

  2024cites this paper
• Novel Insights into the Link Between Myeloperoxidase Modified LDL, LOX-1, and Neuroserpin in Stroke

  2023cites this paper
• Hypochlorous Acid and Chloramines Induce Specific Fragmentation and Cross-Linking of the G1-IGD-G2 Domains of Recombinant Human Aggrecan, and Inhibit ADAMTS1 Activity

  2023cites this paper
• Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor

  2022cites this paper
• Binding of myeloperoxidase to the extracellular matrix of smooth muscle cells and subsequent matrix modification

  2020cites this paper
• The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease

  2020cites this paper
• Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease.

  2020cites this paper
• Myeloperoxidase: Mechanisms, reactions and inhibition as a therapeutic strategy in inflammatory diseases.

  2020cites this paper
• Binding of lactoferrin to the surface of low-density lipoproteins modified by myeloperoxidase prevents intracellular cholesterol accumulation by human blood monocytes.

  2020cites this paper
• Full-field optical coherence tomography for the diagnosis of giant cell arteritis

  2020cites this paper
• The Role of Halogenative Stress in Atherogenic Modification of Low-Density Lipoproteins

  2020cites this paper
• Effect of myeloperoxidase modified LDL on bovine and human aortic endothelial cells

  2019cites this paper
• Binding of Myeloperoxidase to the Extracellular Matrix of Smooth Muscle Cells and Subsequent Matrix Modification

  2019cites this paper
• Hypochlorous acid-modified extracellular matrix contributes to the behavioral switching of human coronary artery smooth muscle cells.

  2019cites this paper
• Large-scale gene analysis of rabbit atherosclerosis to discover new biomarkers for coronary artery disease

  2019cites this paper
• Detection, identification, and quantification of oxidative protein modifications

  2019cites this paper
• Iodide modulates protein damage induced by the inflammation-associated heme enzyme myeloperoxidase

  2019cites this paper
• Chlorination and oxidation of the extracellular matrix protein laminin and basement membrane extracts by hypochlorous acid and myeloperoxidase

  2018cites this paper
• Apoliporotein L3 interferes with endothelial tube formation via regulation of ERK1/2, FAK and Akt signaling pathway.

  2018cites this paper
• Oxidation of cysteine by ceruloplasmin leads to formation of hydrogen peroxide, which can be utilized by myeloperoxidase.

  2018cites this paper
• Enzymatic and bactericidal activity of myeloperoxidase in conditions of halogenative stress.

  2018cites this paper
• The Role Of Thiocyanate In Modulating Tissue Damage In Cardiovascular Disease

  2017cites this paper
• Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction

  2017cites this paper
• Detailed protocol to assess in vivo and ex vivo myeloperoxidase activity in mouse models of vascular inflammation and disease using hydroethidine.

  2016cites this paper
• Differential effects of chlorinated and oxidized phospholipids in vascular tissue: implications for neointima formation.

  2015cites this paper
• Modulation of oxidative damage by selenium compounds

  2015cites this paper
• Rational drug design applied to myeloperoxidase inhibition.

  2015cites this paper
• Rational drug design applied to myeloperoxidase inhibition

  2015cites this paper
• Effect of MPO/H2O2/NO(-) system on nitric oxide-mediated modification of TTR amyloid and serum TTR in FAP ATTR Val30Met patients.

  2014cites this paper
• Proatherogenic modification of LDL by surface-bound myeloperoxidase.

  2014cites this paper
• Effect of MPO / H 2 O 2 / NO-system on nitric oxide-mediated modification of TTR amyloid and serum TTR in FAP ATTR Val 30 Met patients

  2014cites this paper
• Hypohalous acid-modified human serum albumin induces neutrophil NADPH oxidase activation, degranulation, and shape change.

  2014cites this paper
• Oxidation modifies the structure and function of the extracellular matrix generated by human coronary artery endothelial cells.

  2014cites this paper
• In vitro oxidative footprinting provides insight into apolipoprotein B‐100 structure in low‐density lipoprotein

  2014cites this paper
• The smoking-associated oxidant hypothiocyanous acid induces endothelial nitric oxide synthase dysfunction.

  2014cites this paper
• Aus der Klinik für Allgemeine und Interventionelle Kardiologie des Universitären

  2013cites this paper
• Hypochlorous acid as a precursor of free radicals in living systems

  2013cites this paper
• Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells.

  2013cites this paper
• Biological markers of oxidative stress: Applications to cardiovascular research and practice☆

  2013cites this paper
• Myeloperoxidase modulates human platelet aggregation via actin cytoskeleton reorganization and store-operated calcium entry

  2013cites this paper
• Myeloperoxidase in cardiovascular disease.

  2013cites this paper
• Rationale for a Novel Nutraceutical Complex : Potassium Taurine Bicarbonate

  2013cites this paper
• Human serum albumin modified under oxidative/halogenative stress enhances luminol-dependent chemiluminescence of human neutrophils

  2013cites this paper
• The involvement of modified lipids in vascular injury and disease

  2013cites this paper
• Therapeutic Lifestyle Modification Program Reduces Plasma Levels of the Chemokines CRP and MCP-1 in Subjects With Metabolic Syndrome

  2013cites this paper
• Subjects With Metabolic Syndrome Therapeutic Lifestyle Modification Program Reduces Plasma Levels of the Chemokines CRP and MCP-1 in

  2012cites this paper
• Hypothiocyanous acid: benign or deadly?

  2012cites this paper
• Myeloperoxidase-derived oxidants inhibit sarco/endoplasmic reticulum Ca2+-ATPase activity and perturb Ca2+ homeostasis in human coronary artery endothelial cells.

  2012cites this paper
• A novel flow-injection analysis system for evaluation of antioxidants by using sodium dichloroisocyanurate as a source of hypochlorite anion.

  2012cites this paper
• Preventing protein oxidation with sugars: scavenging of hypohalous acids by 5-selenopyranose and 4-selenofuranose derivatives.

  2012cites this paper
• Current role of myeloperoxidase in routine clinical practice

  2011cites this paper
• Synthesis and antioxidant evaluation of novel indole-3-acetic acid analogues

  2011cites this paper
• Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects

  2010cites this paper
• Molecular probes for biologically important molecules: A study of thiourea, hydroxyl radical, peroxynitrite and hypochlorous acid

  2010cites this paper
• Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall.

  2010cites this paper
• The role of hypothiocyanous acid (HOSCN) in biological systems

  2009cites this paper
• Role of -463G/A Promoter Polymorphism of Myeloperoxidase in the Development of Atherosclerosis

  2009influential citation
• The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.

  2008influential citation
• Mammalian Heme Peroxidases: From Molecular Mechanisms to Health Implications

  2008cites this paper
• Identification of plasma proteins that are susceptible to thiol oxidation by hypochlorous acid and N-chloramines.

  2008cites this paper
• Oxidation of methionine 63 and 83 regulates the effect of S100A9 on the migration of neutrophils in vitro

  2007cites this paper
• Reprint of "oxidative alterations of cyclooxygenase during atherogenesis" [Prostag. Oth. Lipid. M. 80 (2006) 1-14].

  2007cites this paper
• l-Arginine Chlorination Results in the Formation of a Nonselective Nitric-Oxide Synthase Inhibitor

  2006cites this paper
• Rationale for a novel nutraceutical complex 'K-water': potassium taurine bicarbonate (PTB).

  2006cites this paper
• Adhesion and infiltration of leukocytes into the vessel wall are critical components of tissue injury induced under these inflammatory conditions

  2006cites this paper
• Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases.

  2006cites this paper
• Antioxidant activity of a catechol derived from abietic acid.

  2006cites this paper
• Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia.

  2006cites this paper
• Oxidative alterations of cyclooxygenase during atherogenesis.

  2006cites this paper
• Myeloperoxidase predicts progression of carotid stenosis in states of low high-density lipoprotein cholesterol.

  2006cites this paper
• ATVB in Focus Redox Mechanisms in Blood Vessels

  2005cites this paper
• Myeloperoxidase: friend and foe

  2005cites this paper
• Statins downregulate myeloperoxidase gene expression in macrophages.

  2005cites this paper
• Measurement of antioxidative activity against hypochlorite ion by sequential injection analysis with luminol chemiluminescence detection

  2004cites this paper
• Peroxynitrite-mediated α-tocopherol oxidation in low-density lipoprotein: a mechanistic approach

  2004cites this paper
• Lipid oxidation in atherogenesis: an overview.

  2004cites this paper
• Contribution PEROXYNITRITE-MEDIATED a-TOCOPHEROL OXIDATION IN LOW-DENSITY LIPOPROTEIN : A MECHANISTIC APPROACH

  2004cites this paper
• Role of oxidative modifications in atherosclerosis.

  2004cites this paper
• Peroxynitrite-mediated alpha-tocopherol oxidation in low-density lipoprotein: a mechanistic approach.

  2004cites this paper
• Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.

  2003cites this paper
• Fragmentation of extracellular matrix by hypochlorous acid.

  2003cites this paper
• Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation.

  2003cites this paper
• Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases.

  2003cites this paper
• Effects of hypochlorite and hydrogen peroxide on cardiac autonomic receptors and vascular endothelial function

  2003cites this paper
• Isoflavone effects on cardiovascular risk factors and arterial function Related review: Isoflavones: their effects on cardiovascular risk and functions (pp 3–8)

  2003cites this paper
• Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency

  2003cites this paper
• Hyperlipidaemia and cardiovascular disease.

  2002cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper